Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-2808 in MSA-P
NCT07825402Phase 3Not yet recruiting
- Sponsor
- Ono Pharmaceutical
- Start
- Jan 2027
- Primary completion
- Oct 2029
01
Overview
A Phase 3 trial of ONO-2808 in multiple system atrophy (MSA), sponsored by Ono Pharmaceutical. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
ONO-2808
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT07825402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07825402.